The FDA announced on 2018-11-27 that ICU Medical, Inc. is recalling Transpac IV Monitoring Kits due to pressure tubing separation risks. The hazard could lead to therapy delays, blood loss, air embolism, or contamination. This voluntary Class II recall involves 5,000 units distributed in the U.S. and Canada.
How to tell if you have it
- Brand: ICU Medical
- Product: Transpac IV Monitoring Kit With Safeset Reservoir and Blood Sampling Port, 152 cm (60") Tubing, Disposable Transducer, 03 ml Squeeze Flush Device, Macrodrip (Pole Mount)
- REF: 01C-42640-06
- Lot/UDI: 3514084/ (01)0 0840619 03747 5 (17) 201001 (30) 01 (10) 3514084
- Lot/UDI: 3550279/ (01)0 0840619 03747 5 (17) 201001 (30) 01 (10) 3550279
The hazard
Reports indicate pressure tubing separation between the sampling port and high pressure tubing on certain lots of extravascular blood pressure transducers. This failure could lead to delay in therapy, and in rare circumstances, blood loss, air embolism, or contamination of the fluid path.
Context
GovInfoNow's records show ICU Medical, Inc. has 60 other recalls on record since 2017-06-15. Recent brand recalls include a 2026-08-20 CADD Yellow Medication Cassette Reservoir Recall for leakage risk and a 2026-06-24 Hotline Fluid Warming Set Recall for leakage in specific lots. Other recent recalls of similar products include Medtronic DLP Retrograde Cannula Recall (2026-04-21), Medtronic DLP Cannula Recall (2026-04-21), and B Braun Medical Blood Set Recall (2025-10-29).